Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg

We investigated the frequency and serological correlates of occult hepatitis B virus infection (OBI) and the potential impact of a highly sensitive assay for HBsAg in subjects infected by human immunodeficiency virus (HIV) or hepatitis C virus (HCV), who are also at risk for hepatitis B virus (HBV)...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Silvia Meschi, Klizia Mizzoni, Bruno Daniele Leoni, Claudio Galli, Anna Rosa Garbuglia, Stefano Belladonna, Enrico Girardi, Fabrizio Maggi, the HBSAGN Study Group
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	occult hepatitis B (OBI) HBV-DNA anti-HBc HBsAg HCV HIV
Online Access:	https://www.mdpi.com/1999-4915/16/3/412

Similar Items

Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay
by: Shi Song, et al.
Published: (2025-05-01)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
by: Xin Liu, et al.
Published: (2023-08-01)

Potential infectivity of blood from HBsAG asymptomatic carriers due to the presence of HBV-DNA and comparison with other markers of hbv infection Potencial de infectividade em sangue de portadores assintomáticos de HBsAg caracterizado pela presença de HBV-DNA e comparação com outros marcadores da Hepatite B.
by: M. Valeria Tedeschi, et al.
Published: (1989-12-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Occult HBV infection
by: I.A. Zaytsev
Published: (2018-04-01)

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01)

Seroprevalence and sociodemographic determinants of HBsAg and Anti-HBC in Malaysia's nationwide population
by: Nurfatehar Ramly, et al.
Published: (2025-09-01)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

Using the Quantitative Determination of HbsAg to Monitor Antiviral Therapy of Chronic HBV-Infection
by: I.A. Zaitsev
Published: (2015-04-01)

The relation of polymorphisms in +874 region of IFN-Gama with occult HBV infection
by: Kazemi Arababadi M (PhD), et al.
Published: (2010-03-01)

Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting
by: Shreyasi Athalye, et al.
Published: (2024-02-01)

Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg
by: Yu Yu, et al.
Published: (2022-09-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy
by: Muye Xia, et al.
Published: (2025-02-01)

Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-Campinas Prevalence of HBsAg, anti-HBc and anti-HCV in the blood donors of "Hemocentro-Campinas"
by: Fernando Lopes Gonçales Júnior, et al.
Published: (1993-02-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Rosini Nilton, et al.
Published: (2003-01-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
by: Ying Yan, et al.
Published: (2022-11-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia
by: Marina Bubonja-Šonje, et al.
Published: (2024-01-01)

Multi-omic molecular characterization and diagnostic biomarkers for occult hepatitis B infection and HBsAg-positive hepatitis B infection
by: Xinyi Jiang, et al.
Published: (2024-11-01)

Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy
by: Alessia Sticchi Damiani, et al.
Published: (2023-12-01)

Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region
by: Ahmed Subeh Alshrari, et al.
Published: (2025-02-01)

Detection and prevalence of HBsAg and HBV DNA among visiting patients attending health facilities in Nigeria
by: Uchenna D. Abazuh, et al.
Published: (2023-07-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy
by: Yingfu Zeng, et al.
Published: (2024-03-01)

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
by: Min You, et al.
Published: (2023-12-01)

Confirmation of HBV infection of HBsAg-negative NAT suspicious sample from blood donors
by: Quanhui WANG, et al.
Published: (2023-12-01)

Incidence of anti-HBc antibody (IgG and IgM) among HBsAg negative apparently healthy blood donors
by: Nittyananda Shil, et al.
Published: (2016-12-01)

Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain
by: Lanlan Liu, et al.
Published: (2024-07-01)

Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis
by: Ummi Maimunah, et al.
Published: (2024-05-01)

HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
by: Maki Ohkubo, et al.
Published: (2023-12-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors
by: J.S.F. Pereira, et al.
Published: (2006-04-01)

Anti-HBc IgG Responses Occurring at the Early Phase of Infection Correlate Negatively with HBV Replication in a Mouse Model
by: Xuyang Wang, et al.
Published: (2022-09-01)

OCCULT HEPATITIS B VIRUS INFECTION AMONG PATIENTS WITH LIVER DYSFUNCTION IN VARNA, BULGARIA
by: Denitsa Tsaneva-Damyanova, et al.
Published: (2018-10-01)

Seroprevalence of HIV-HBV Co-Infection
by: Suresh B. Sonth, et al.
Published: (2012-04-01)

Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains
by: Lu Zhang, et al.
Published: (2019-01-01)